FRANK GERALD TALON: Open Payments
NPI 1558042317 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,318 in 109 payments from 17 companies in 2025. Trend: 2023 $409 · 2024 $2,219 · 2025 $3,318
Food & beverage: $3,318
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $950 |
| Madrigal Pharmaceuticals | 14 | $640 |
| Aimmune Therapeutics, Inc. | 8 | $314 |
| Lilly USA, LLC | 6 | $201 |
| Ipsen Biopharmaceuticals, Inc | 5 | $186 |
| GENZYME CORPORATION | 4 | $186 |
| Gilead Sciences, Inc. | 3 | $177 |
| QOL Medical, LLC | 8 | $168 |
| Janssen Biotech, Inc. | 5 | $143 |
| Phathom Pharmaceuticals, Inc. | 3 | $127 |
Products named: REZDIFFRA, RINVOQ, SKYRIZI, ZENPEP, DUPIXENT, OMVOH, Sucraid, TREMFYA.
Industry payments across NV — which companies pay providers there.
